Significant Ownership of Pivotal bioVenture Partners Fund I, L.P.

Signature - Title
Pivotal bioVenture Partners Fund I G.P., L.P. - its general partner
Location
San Francisco, CA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Pivotal bioVenture Partners Fund I, L.P..

Notify me when Pivotal bioVenture Partners Fund I, L.P. files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Pivotal bioVenture Partners Fund I, L.P.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
OCS Oculis Holding AG Ordinary Shares, CHF 0.01 par value per share 4.9% $49.9M 2.82M Nan Fung Group Holdings Limited Sep 30, 2025
INZY Inozyme Pharma, Inc. Common Stock, par value $0.0001 per share 0% $0 0 Pivotal bioVenture Partners Fund I, L.P. Jul 1, 2025

Schedules 13D/G Reported by Pivotal bioVenture Partners Fund I, L.P.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.